genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Fathers’ Secondhand Smoke Puts Unborn Babies at Risk of Heart Defects
News
Chemicals in Household Dust Linked to Fat Cell Development
News
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene…
News
Cells Undergo Past Life Regression
News
Omega-3 Deficiency Underlies Peripheral Artery Disease
Insights
Insights
Top 10 Immuno-Oncology Collaborations
Insights
Could Crocus Sativus (Saffron) Be as Effective as Stimulant Medicines in…
Commentary
Limitations in Single-Cell Analysis Must Be Addressed with Innovation
Cannabinoids
Liquid Gold: Engineers Strike Oil Making Customized Extractors for Cannabis
Bioprocessing
Addressing Challenges Posed by the Adoption of Single-Use Systems
A-Lists
Insights
Top 10 Immuno-Oncology Collaborations
Insights
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
March 2019 Vol. 39 No. 3
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Insights
Top 10 Immuno-Oncology Collaborations
News
Address Manufacturing and Look Beyond Cancer, Panel Advises Cell and Gene…
News
Cells Undergo Past Life Regression
News
Omega-3 Deficiency Underlies Peripheral Artery Disease
Magazine
All
Supplement
Insights
Phage Therapy: Turning the Tables on Bacteria
March 2019 Vol. 39 No. 3
Keeping Up with Bioprocess Changes
March 2019 Vol. 39 No. 3
Circulating Tumor Cells and the Liquid Biopsy
Insights
Novel Oncology Drug Discovery Strategies
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
Multiplexed Target Enrichment and High-Resolution NGS Analysis of On- and…
Webinars
Fibro-Inflammatory Disease Sees Relief in IL-11 mAb Development
eBooks
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
GENcast
GENcast: Explore, Learn, and Collaborate on Cell & Gene Therapy Manufacturing…
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Companies
AstraZeneca
AstraZeneca
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AstraZeneca
Moderna Raises Size of its Largest-Ever Biotech IPO to $600M
AstraZeneca
AstraZeneca’s Imfinzi Fails 2nd Primary Endpoint in Phase III MYSTIC Trial
AstraZeneca
Sobi Buys Synagis U.S. Rights, Half Share of MEDI18897 U.S. Profits from AstraZeneca
AstraZeneca
Grünenthal Acquires Partial Rights to Nexium, Vimovo from AstraZeneca for Up-to-$922M
AstraZeneca
After Second Phase III Failure, AstraZeneca Retreats from COPD Filing Plans for Fasenra
AstraZeneca
AstraZeneca Weighs Expanding Fasenra to COPD after Phase III Failure
AstraZeneca
AstraZeneca, SWIBCo Launch Stem Cell Cardiovascular Therapy Collaboration
AstraZeneca
After Patient Dies, FDA Imposes Clinical Hold on Trial of Advaxis/AstraZeneca...
AstraZeneca
With $250M in Financing, AstraZeneca Spinout to Focus on Severe Autoimmune...
AstraZeneca
Bavarian Nordic Launches Study of Cancer Vaccine CV301 with AstraZeneca’s Imfinzi
AstraZeneca
Moderna Raises $500M Financing for mRNA R&D, Manufacturing
AstraZeneca
Regeneron to Lead $50M Exome Sequencing Consortium with UK Biobank
AstraZeneca
PhaseBio Inks License to Develop MedImmune’s Reversal Agent for Blood Thinner
AstraZeneca
AstraZeneca Asthma Candidate Tralokinumab Fails Two Phase III Trials
AstraZeneca
Takeda to Codevelop AstraZeneca’s Clinic-Bound Parkinson’s Candidate MEDI1341
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
